03/16/2026
Happening Today! 🙌
Presenting Liquid Biopsy Labs’ Groundbreaking 🩸 LRNA Test at ESMO Targeted Anticancer Therapies Congress 🩺
We are so excited for today’s presentation of our Liquid RNA abstract at the ESMO Targeted Anticancer Therapies Congress 2026!
Our co-founder and CEO, Michelle Morand, is in Paris right now representing Liquid Biopsy Labs at the ESMO Congress in Paris –
And she will be presenting our abstract at 5:30pm CET today!
The ESMO Targeted Anticancer Therapies Congress brings together global leaders in oncology drug development and precision medicine. 🧬
We are honoured to contribute to this important scientific dialogue and to showcase the innovation behind our L-RNA platform.
If you are attending ESMO TAT 2026 in Paris, we invite you to visit our presentation and connect with us in person!
We look forward to meaningful conversations and new collaborations in Paris. 😊
If you would like to attend, here are the details:
Abstract: “Clinical Performance Of Novel Exosomal Liquid RNA Biopsy Assay In Lung Cancer Segment”
Presentation Number: 139P
Speakers: Michelle Morand (Vancouver, Canada)
Session Name: Poster Display session & networking reception
Location: Foyer, Palais des Congrès, Paris, France
Date: Mon, March 16, 2026
Time 5:30pm to 6:30pm CET
You can see the full program here:
https://www.esmo.org/meeting-calendar/esmo-targeted-anticancer-therapies-congress-2026
👉 If you would like to meet with Michelle Morand during her stay in Paris, please email [email protected]
➡️ To order or learn more about this groundbreaking LRNA test for early detection of cancer → https://www.liquidbiopsylabs.com/